4SC AG Invites Shareholders to Annual General Meeting 2025
On July 23, 2025, 4SC AG, a biotechnology company specializing in the development of novel small molecule drugs for cancer treatment, announced the invitation to its annual general meeting (AGM) for 2025. The meeting is scheduled to take place in Planegg-Martinsried, Germany, and is in accordance with Section 121, Paragraph 4a of the German Stock Corporation Act (AktG).
Key Details of the AGM:
- Date and Time: The AGM is set for Friday, with the exact date and time to be confirmed.
- Location: Planegg-Martinsried, Germany.
- Event Identification: The unique identifier for this event is VSC092025oHV.
- Stock Information: 4SC AG is listed on the Frankfurt Stock Exchange with the stock ticker A3E5C4 and ISIN DE000A3E5C40.
Company Overview:
4SC AG operates within the healthcare sector, focusing on biotechnology. The company has experienced significant fluctuations in its stock price over the past year, with a 52-week high of €8.96 on September 15, 2024, and a 52-week low of €0.40 on July 2, 2025. As of July 20, 2025, the closing price was €0.944. The company’s market capitalization stands at €10,690,000, and it has a price-to-earnings ratio of -1.46, reflecting its current financial performance.
Shareholder Invitation:
The invitation extends to all shareholders of 4SC AG, encouraging their participation in the AGM. The meeting will address key topics relevant to the company’s strategic direction, financial performance, and future initiatives in cancer treatment drug development.
For further details, shareholders are advised to refer to the official invitation documents and announcements from 4SC AG.
This article provides a concise overview of the upcoming AGM for 4SC AG, highlighting the essential details and context for shareholders and interested parties.